THTakaharu Hayashi

Takaharu Hayashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takaharu Hayashi has a total of 189 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Risk Estimation by the PREVENT equations and Clinical Outcome in Patients with Heart Failure with Preserved Ejection Fraction

    by Katsuomi Iwakura, Nobuaki Tanaka, Masato Okada, Akito Nakagawa, Shunsuke Tamaki, Masahiro Seo, Takahisa Yamada, Masamichi Yano, Takaharu Hayashi, Yoshio Yasumura, et al.

    Background: The PREVENT (Predicting Risk of CVD EVENTs) equations estimate the risk of incident cardiovascular disease (CVD) in primary prevention patients. We hypothesized that risk factors incorporated in the equations may be relevant to prognosis in heart failure (HF) and investigated the association between estimated CVD risk and clinical outcomes in patients with preserved ejection fraction (HFpEF). Methods: We estimated the 10-year CVD risk using the PREVENT equations in 278 patients hospitalized for acutely decompensated HFpEF (median 75 years, 51.4% male). We divided them into four groups according to the quartiles of estimated CVD risk and followed them to observe major adverse cardiovascular events (MACE), a composite of all-cause death, HF hospitalization, and stroke. Results: MACE occurred in 125 patients (45.0%) over a median follow-up of 1,050 days. The estimated CVD risk classification was an independent predictor for MACE (p=0.02) in the multivariable Cox proportional hazard model. There was a difference in MACE-free survival across the four quartile groups (p<0.001 by log-rank test), and the lowest CVD risk group had significantly lower MACE incidence than other groups. The estimated CVD risk provided incremental prognostic value beyond N-terminal pro-B type natriuretic peptide (C-index: 0.626 vs, P=0.009). The predictive value of the estimated CVD risk for MACE at 1 year was comparable to that of the MAGGIC score (AUC 0.676 vs. 0.639, p=0.42). Conclusions: The 10-year CVD risk estimated by the PREVENT equations had a moderate predictive value for MACE in patients hospitalized for HFpEF.

  • Open Access

    Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction

    by Masato Okada, Nobuaki Tanaka, Katsuomi Iwakura, Toshinari Onishi, Masahiro Seo, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Shunsuke Tamaki, et al.

    Background: Left atrial (LA) dysfunction is common in heart failure with preserved ejection fraction (HFpEF). The LA volumetric/mechanical coupling index (LACI), calculated as the LA volume index divided by the late diastolic mitral annular velocity (a′), is a recently advocated parameter reflecting LA contractile function based on the atrial Frank–Starling mechanism. An elevated LACI signifies impaired mechanical performance despite greater atrial volume, indicating volumetric/mechanical uncoupling. Its associations with echocardiographic indices and prognostic significance in HFpEF remain unclear. Methods: This study included 562 patients from the PURSUIT‐HFpEF (Prospective Multicenter Observational Study of Patients With Heart Failure With Preserved Ejection Fraction) registry, a prospective multicenter registry for HFpEF. LACI was calculated and categorized into quartiles. Associations with echocardiographic indices and clinical outcomes were examined. Results: LA volume index and late diastolic mitral annular velocity were negatively correlated ( r =−0.26; P P =0.001). After multivariable adjustment, LACI remained a significant predictor of cardiovascular outcomes (hazard ratio, 1.18 per quartile increase [95% CI, 1.00–1.38]; P =0.045). Conclusions: In patients with HFpEF, LA mechanical activity decreased with LA enlargement, suggesting volumetric/mechanical uncoupling inherent in this cohort. LACI may serve as a clinically relevant index for risk stratification of cardiovascular death or rehospitalization for heart failure in patients with HFpEF. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: UMIN000021831.


  • Open Access

    Association between Triglyceride-Glucose Index and Clinical Outcome in Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction

    by Katsuomi Iwakura, Atsunori Okamura, Yoshitaka Iwanaga, Yasushi Koyama, Nobuaki Tanaka, Masato Okada, Masahiro Seo, Takahisa Yamada, Masamichi Yano, Takaharu Hayashi, et al.

    Background: Although insulin resistance (IR) is associated with a higher risk of incident heart failure (HF), it is not fully understood whether IR could affect clinical outcomes in patients with established HF. We investigated the relationship between the triglyceride-glucose (TyG) index, a simple surrogate marker for IR, and clinical outcomes in patients with HF with preserved ejection fraction (HFpEF). Methods: This retrospective analysis from the PURSUIT-HFpEF registry included 917 patients hospitalized for decompensated HFpEF. The TyG index was calculated at discharge as ln(triglyceride [mg/dL] × fasting blood glucose [mg/dL]/2). The primary outcomes were all-cause death and major adverse cardiovascular events (MACEs; a composite of all-cause death, heart failure hospitalization, and stroke). Results: The median age of patients was 83 years, 44.7% was male, and 39.2% had diabetes. The median BMI was 21.5 kg/m², with 20.9% having BMI <18.5 kg/m ². During a median follow-up of 387 days, 168 deaths and 343 MACEs occurred. A stepwise Cox hazard model revealed that higher TyG index was independently associated with lower risk of all-cause death (HR 0.53, 95% CI 0.38-0.75) and MACEs (HR 0.77, 95% CI 0.61-0.97). When patients were divided into quartiles based on TyG index, the incidences of both outcomes were significantly lower in higher TyG quartiles (all-cause death; p=0.0003, MACEs; p=0.007 by log-rank). Conclusions: In this predominantly elderly, low BMI cohort with established HFpEF, higher TyG index was paradoxically associated with better clinical outcomes. These findings imply a complex relationship between IR and HFpEF outcomes. Clinical Perspective: 1) What is new?: The triglyceride-glucose (TyG) index is a novel, easily calculated surrogate marker for insulin resistance (IR) using only serum triglyceride and fasting blood glucose levels. A higher TyG index, reflecting greater IR, was paradoxically associated with a lower incidence of all-cause mortality and major adverse cardiovascular events in patients hospitalized with heart failure with preserved ejection fraction (HFpEF) over approximately one year of follow-up. This association remained consistent across various subgroups stratified by age, sex, BMI, diabetes status, and other risk factors. 2) What are the clinical implications?: A paradoxical relationship between IR and clinical outcomes may exist in predominantly older, low-BMI Japanese patients with established HFpEF. The prognostic impact of IR in established heart failure appears complex and may vary depending on patient characteristics.

  • Open Access

    Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Study

    by Yuki Matsuoka, Yohei Sotomi, Daisaku Nakatani, Katsuki Okada, Akihiro Sunaga, Hirota Kida, Taiki Sato, Daisuke Sakamoto, Tetsuhisa Kitamura, Sho Komukai, et al.

    Background: Using machine learning for the phenotyping of patients with heart failure with preserved ejection fraction (HFpEF) has emerged as a novel approach to understanding the pathophysiology and stratifying the patients. Our objective is to perform phenotyping of patients with HFpEF in stable phase and to investigate the phenotypic trajectory from acute worsening phase to stable phase. Methods: The present study is a post hoc analysis of the PURSUIT‐HFpEF (Prospective Multicenter Observational Study of Patients with Heart Failure with Preserved Ejection Fraction) study. We applied the latent class analysis to the discharge data of patients hospitalized for acute decompensated heart failure. Results: We finally included patient data of 1100 cases and 63 features in the latent class analysis. All patients were subclassified into 5 phenogroups as follows: Phenotype 1, characterized by better renal function and lower NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) level [N=325 (29.5%)]; Phenotype 2, higher blood pressure, sinus rhythm, and poor renal function. [N=242 (22.0%)]; Phenotype 3, higher prevalence of atrial fibrillation, higher tricuspid pressure gradient, and lower tricuspid annular plane systolic excursion [N=214 (19.5%)]; Phenotype 4, higher C‐reactive protein level and higher tricuspid pressure gradient [N=245 (22.3%)]; and Phenotype 5, poor nutritional status, poor renal function, and higher NT‐proBNP level [N=74 (6.7%)]. A particular phenotype observed at the time of discharge was correlated with a distinct phenotype of acute worsening. Conclusions: We identified 5 distinct stable phase phenotypes of the patients with HFpEF from the data at discharge. A specific phenotype at discharge was associated with a particular phenotype of acute worsening. This grouping can be a basis for future precision medicine of patients with HFpEF. Registration: URL: https://www.umin.ac.jp/ctr/ ; Unique identifier: UMIN000021831.


  • Open Access

    Alternative Factors in Possible Involvement of Coronary Microvascular Dysfunction in Older Patients with HFpEF

    by Shiro Hoshida, Tetsuya Watanabe, Nobutaka Masunaga, Yukinori Shinoda, Masahiro Seo, Takaharu Hayashi, Masamichi Yano, Takahisa Yamada, Yoshio Yasumura, Shungo Hikoso, et al.

    Objectives: Coronary microvascular dysfunction (CMD) is associated with many heart diseases, including heart failure (HF) with preserved ejection fraction (HFpEF). Invasive examinations for CMD detection are difficult in older patients with HFpEF, and the decision criteria for noninvasive CMD measurements are unclear. We aimed to identify alternative factors in the possible involvement of CMD in the progression and prognosis of HFpEF. Methods: We analyzed 607 patients with HFpEF who were hospitalized for acute decompensated HF without a history of coronary artery disease (CAD). Blood tests and transthoracic echocardiography were performed. We focused on left ventricular hypertrophy (LVH) and coronary perfusion pressure (diastolic blood pressure, dBP). Results: The patients with LVH showed reduced diastolic function (E/e’) and a lower incidence of atrial fibrillation (AF) compared with those without LVH, with no differences in age or dBP. No differences were observed in all-cause mortality between patients with low and high dBP without LVH. In the patients with LVH, the incidence of all-cause mortality was significantly higher, with a lower incidence of AF, reduced renal function, and higher C-reactive protein levels in those with low dBP than in those with high dBP. The comprehensive diastolic functional index, diastolic elastance/arterial elastance, was markedly higher in the patients with LVH, especially in those with all-cause mortality. This index, but not E/e’, was a significant prognostic index in the multivariate Cox hazard analysis when adjusting for age, sex and N-terminal pro-brain natriuretic peptide levels. Conclusions: LVH and dBP were clinically important factors in elderly HFpEF patients without a history of CAD.

  • Open Access

    Cor triatriatum sinister in an elderly woman patient with successful conservative treatment

    by Kana Inami, Ryuta Sugihara, Masahiro Kumada, Takaharu Hayashi, Hidetada Fukuoka, Naoki Fukushima, Tsutomu Nakagawa, Yasushi Sakata

    Cor triatriatum sinister (CTS) is a relatively rare congenital condition characterized by an abnormal septum dividing the left atrium, morphologically presenting as three atria. Although most individuals with heart failure related to CTS undergo surgical treatment in childhood, those with larger fenestrations may remain asymptomatic until they reach an age where surgery is less viable, presenting treatment challenges. In our case study, we report on an elderly woman who declined all invasive treatments and developed heart failure due to severe functional mitral valve regurgitation triggered by atrial fibrillation. She opted for conservative treatment after a comprehensive evaluation of her condition using transesophageal echocardiography, cardiac magnetic resonance imaging, and right-heart catheterization. This multimodal evaluation highlights the importance of accurate diagnostic approaches and tailored treatments for elderly patients with CTS.


  • Open Access

    Pathophysiological insights into machine-learning-based subphenotypes of acute heart failure with preserved ejection fraction: a biomarker analysis of PURSUIT-HFpEF registry

    by Y Sotomi, S Tamaki, S Hikoso, D Nakatani, K Okada, T Dohi, M Seo, Y Masamichi, T Hayashi, A Nakagawa, et al.

    Background: Our understanding of heart failure with preserved ejection fraction (HFpEF) has evolved from mere left ventricular diastolic dysfunction to a multiorgan disease. Purpose: This study aimed to investigate the heterogeneous pathophysiology of the several phenotypes of HFpEF with multiple biomarker data. Methods: This study is a post-hoc analysis of the PURSUIT-HFpEF study (N=1,231), an ongoing, prospective, multi-referral center, observational study of acute decompensated HFpEF [UMIN000021831]. In this registry, there is a pre-defined sub-cohort in which we perform multi-biomarker tests (N=212). We applied the machine-learning-based clustering model that we have previously established to the sub-cohort and classified them into 4 phenotypes: phenotype 1 labeled as "rhythm trouble" (n=69), phenotype 2 "ventricular-arterial uncoupling" (n=49), phenotype 3 "low output and systemic congestion" (n=41), and phenotype 4 "systemic failure" (n=53). Characteristics of biomarker tests in each phenotype were evaluated. Results: The phenotype 2 characterized by hypertension and cardiac hypertrophy showed the highest value of N-terminal pro-brain natriuretic peptide (NT-proBNP), IL-16, high-sensitive C-reactive protein (CRP), tumor necrosis factor (TNF)-α, growth differentiation factor (GDF)-15, troponin T, and cystatin C, whereas the phenotype 1 presented the lowest value of these markers. The phenotype 3 showed the second highest value of GDF-15 and cystatin C. The phenotype 4 presented a low NT-proBNP value and a relatively high GDF-15. Conclusions: The specific characteristics of biomarkers in each phenotype confirmed the validity of the machine learning model-based classification. The contribution of inflammation to the pathogenesis considerably differed in different HFpEF phenotypes. Systemic inflammation substantially contributes to the pathophysiology of the classical HFpEF phenotype with cardiac hypertrophy.

  • Open Access

    Left atrioventricular coupling index as a prognostic marker of cardiovascular events in heart failure with preserved ejection fraction

    by M Okada, N Tanaka, K Iwakura, M Seo, T Hayashi, M Yano, A Nakagawa, Y Nakagawa, S Tamaki, T Yamada, et al.

    Background: Left atrial (LA) structural remodeling is common and considered a marker of increased mortality in patients with heart failure with preserved ejection fraction (HFpEF). However, the left atrium is directly connected to the left ventricle during diastole and their functions are tightly coupled. A single left atrioventricular coupling index (LACI), defined by the ratio between the LA end-diastolic volume (LAV) and the LV end-diastolic volume (LVEDV) assessed by echocardiography, could be useful in the clinical routine to improve the risk stratification of HFpEF. Methods: An analysis was performed from a prospective multicenter observational registry for HFpEF (PURSUIT-HFpEF Registry) conducted in the Osaka region of Japan. A total of 1231 patients hospitalized for acute heart failure (diagnosed by using the Framingham criteria) met the inclusion criteria: left ventricular ejection fraction (LVEF) ≥50% and brain natriuretic peptide ≥100 pg/ml. After excluding patients without persistent atrial fibrillation, we enrolled 863 patients (age, 81 ± 9 years; females, 56.1%; atrial fibrillation, 37.2%) whose LAV and LVEDV using the Simpson’s method were available at discharge. Heart failure hospitalizations and cardiovascular deaths were the primary endpoint. Results: There was little correlation between the LAVI (median 50.2, interquartile range [IQR] 37.1–65.4 ml) and LVEDV (median 80.0, IQR 58.3–102.8 ml) (r = 0.16, p <0.001). As a result, the overall LACI was 0.94 (IQR 0.65–1.34). During a median follow-up of 729 (IQR 407–1180) days after discharge, 304 patients experienced the primary endpoint. The incidence incrementally increased with the LACI quartile groups (Q1: 26.9%, Q2: 37.5%, Q3: 34.0%, Q4: 42.6%, log-rank p = 0.005). After adjusting for age, gender, body mass index, left ventricular filling pressure, and serum brain natriuretic peptide levels, the LACI (hazard ratio, 1.19 per quartile increase; 95% confidence interval, 1.03-1.38; p = 0.021) was a significant predictor of the primary endpoint. Conclusions: In the PURSUIT-HFpEF Registry, the degree of LA and LV structural remodeling differed between individuals. The LACI was a novel index for predicting cardiovascular outcomes in patients with HFpEF.


  • Open Access

    Validation of the impact of post discharge change in hemoglobin by renal function on the prognosis of HFpEF patients after acute decompensated heart failure from the PURSUIT-HFpEF registry

    by T Furukawa, S T Tamaki, M Y Yano, T H Hayashi, T Y Yamada, Y Y Yasumura, S H Hikoso, Y S Sotomi, Y S Sakata

    Background: Anemia has been reported as poor prognostic factor on heart failure with preserved ejection fraction (HFpEF). However, it is not clear at what minimum level hemoglobin (Hb) by renal function should be managed to prevent worsening the prognosis of HFpEF. Aim: The aim of this study is to evaluate the impact of the change in Hb by renal function from discharge of congestive heart failure to one year after discharge on the prognosis of HFpEF and verify at what minimum level hemoglobin (Hb) should be managed to prevent worsening the prognosis of HFpEF. Method: 809 HFpEF cases enrolled from 2016 to 2021 in PURSUIT-HFpEF registry were divided into two groups according to estimated glomerular filtration rate (eGFR) at discharge, group with eGFR < 45 (n = 438) and group with eGFR ≥ 45 (n = 371). Two groups were further divided according to whether Hb was above or below 11 < g/dl at discharge: the group with Hb < 11 g/dl was divided into two groups, one with progression anemia (G1) and preserved anemia (G2) after one year, and the group with Hb ≥ 11 g/dl was divided into three groups, Hb < 11 g/dl (G3), 11 g/dl ≤ Hb < 13 g/dl (G4a), Hb ≥ 13 g/dl (G4b). We examined Hazard ratio (HR) and incidence rate of Major Adverse Cardiovascular Events (MACE), all-cause death and heart failure readmission between each two groups, G1 and G2, G3 and G4a, G4a and G4b, and examined predictor for MACE in each two groups with Hb < 11g/dl and ≥ 11 g/dl at discharge by Cox regression model, in two groups with eGFR <45 and ≥ 45 at discharge. Result: All-cause death was significantly lower in G2 than in G1 (HR : 0.33, [95%Confidence Interval (CI), 0.14 - 0.80], p = 0.011) in the group with eGFR ≥ 45. MACE was significantly higher in G3 than in G4a by log-rank test (HR : 1.61, [95%CI, 1.02 - 3.45], p = 0.038) in the group with eGFR < 45, however, MACE, all-cause death and heart failure readmission were significantly higher in G3 than in G4a in the group with eGFR ≥ 45 (MACE ; HR : 1.99, [95%CI, 1.15 - 3.45], p = 0.013, All-cause death ; HR : 2.09, [95%CI, 1.02 - 4.29], p = 0.042, heart failure readmissio ; HR : 2.43, [95%CI, 1.22 - 4.82], p = 0.009). Only all-cause death was significantly lower in G4b than in G4a by log-rank test regardless of renal function (eGFR < 45 ; HR : 0.08, [95%CI, 0.01 - 0.60], p = 0.002, eGFR ≥ 45 ; HR : 0.38, [95%CI, 0.18 - 0.83], p = 0.012). In multivariate Cox regression model, worsening anemia to Hb < 11 g/dl one year later was independent predictor for MACE in patients with eGFR ≥ 45 and Hb ≥ 11 g/dl at discharge (HR : 2.45, [95%CI, 1.22 – 4.91], p = 0.012). Conclusion: Hb levels of at least 11 g/dl should be maintained to prevent the prognosis of HFpEF worse after discharge of acute decompensated heart failure regardless of renal function, however it might be necessary to maintain higher hemoglobin level in HFpEF patients with moderate to severe renal dysfunction than those with mild renal dysfunction.study flow by eGFR and outcomekaplan-meier curves of outcomes